230 related articles for article (PubMed ID: 9333023)
21. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
22. Regulation of caspase-3 and -9 activation in oxidant stress to RTE by forkhead transcription factors, Bcl-2 proteins, and MAP kinases.
Kaushal GP; Liu L; Kaushal V; Hong X; Melnyk O; Seth R; Safirstein R; Shah SV
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1258-68. PubMed ID: 15304372
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 overexpression blocks activation of the death protease CPP32/Yama/apopain.
Monney L; Otter I; Olivier R; Ravn U; Mirzasaleh H; Fellay I; Poirier GG; Borner C
Biochem Biophys Res Commun; 1996 Apr; 221(2):340-5. PubMed ID: 8619857
[TBL] [Abstract][Full Text] [Related]
24. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
25. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.
Lilly M; Sandholm J; Cooper JJ; Koskinen PJ; Kraft A
Oncogene; 1999 Jul; 18(27):4022-31. PubMed ID: 10435626
[TBL] [Abstract][Full Text] [Related]
26. Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases.
Hotti A; Järvinen K; Siivola P; Hölttä E
Oncogene; 2000 May; 19(19):2354-62. PubMed ID: 10822387
[TBL] [Abstract][Full Text] [Related]
27. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway.
Mochizuki T; Kitanaka C; Noguchi K; Muramatsu T; Asai A; Kuchino Y
J Biol Chem; 1999 Jun; 274(26):18659-66. PubMed ID: 10373478
[TBL] [Abstract][Full Text] [Related]
28. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
Wingett D; Reeves R; Magnuson NS
J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
[TBL] [Abstract][Full Text] [Related]
29. Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes.
Inayat-Hussain SH; Couet C; Cohen GM; Cain K
Hepatology; 1997 Jun; 25(6):1516-26. PubMed ID: 9185777
[TBL] [Abstract][Full Text] [Related]
30. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
[TBL] [Abstract][Full Text] [Related]
31. M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways.
Leloup C; Michaelson DM; Fisher A; Hartmann T; Beyreuther K; Stein R
Cell Death Differ; 2000 Sep; 7(9):825-33. PubMed ID: 11042677
[TBL] [Abstract][Full Text] [Related]
32. Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions.
Egger L; Schneider J; Rhême C; Tapernoux M; Häcki J; Borner C
Cell Death Differ; 2003 Oct; 10(10):1188-203. PubMed ID: 14502242
[TBL] [Abstract][Full Text] [Related]
33. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.
Wang Z; Bhattacharya N; Weaver M; Petersen K; Meyer M; Gapter L; Magnuson NS
J Vet Sci; 2001 Dec; 2(3):167-79. PubMed ID: 12441685
[TBL] [Abstract][Full Text] [Related]
34. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N
Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649
[TBL] [Abstract][Full Text] [Related]
35. Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissues.
Roh M; Kim J; Song C; Wills M; Abdulkadir SA
Genesis; 2006 Oct; 44(10):447-53. PubMed ID: 17013838
[TBL] [Abstract][Full Text] [Related]
36. [Apoptosis related gene, Pim-1].
Ariga H; Iguchi-Ariga SM
Nihon Rinsho; 1996 Jul; 54(7):1903-6. PubMed ID: 8741685
[TBL] [Abstract][Full Text] [Related]
37. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
Asano J; Nakano A; Oda A; Amou H; Hiasa M; Takeuchi K; Miki H; Nakamura S; Harada T; Fujii S; Kagawa K; Endo I; Yata K; Sakai A; Ozaki S; Matsumoto T; Abe M
Leukemia; 2011 Jul; 25(7):1182-8. PubMed ID: 21475253
[TBL] [Abstract][Full Text] [Related]
38. The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.
Forshell LP; Li Y; Forshell TZ; Rudelius M; Nilsson L; Keller U; Nilsson J
Oncotarget; 2011 Jun; 2(6):448-60. PubMed ID: 21646687
[TBL] [Abstract][Full Text] [Related]
39. The serine/threonine kinase Pim-1.
Bachmann M; Möröy T
Int J Biochem Cell Biol; 2005 Apr; 37(4):726-30. PubMed ID: 15694833
[TBL] [Abstract][Full Text] [Related]
40. Differential role of the JNK and p38 MAPK pathway in c-Myc- and s-Myc-mediated apoptosis.
Noguchi K; Yamana H; Kitanaka C; Mochizuki T; Kokubu A; Kuchino Y
Biochem Biophys Res Commun; 2000 Jan; 267(1):221-7. PubMed ID: 10623602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
